Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients

Author： Zhong L. Peng X. Hidalgo G.E. Doherty D.E. Stromberg A.J. Hirschowitz E.A.

Publisher： Elsevier

ISSN： 0361-090X

Source： Cancer Detection and Prevention, Vol.27, Iss.4, 2003-01, pp. : 285-290

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancer

By Choi In Keun Kim Yeul Hong Kim Jun Suk Seo Jae Hong

Acta Oncologica, Vol. 49, Iss. 6, 2010-08 ,pp. : 861-864

Informa Healthcare

Access to resources Recommend Favorite

Tumor Cell Expression of Heat Shock Protein (HSP) 72 is Influenced by HSP72 [[HSPA1B A(1267)G]] Polymorphism and Predicts Survival in Small Cell Lung Cancer (SCLC) Patients

By Szondy Klara Rusai Krisztina Szabó Attila J. Nagy Andrea Gal Krisztina Fekete Andrea Kovats Zsuzsanna Losonczy Gyorgy Lukacsovits József Müller Veronika

Cancer Investigation, Vol. 30, Iss. 4, 2012-04 ,pp. : 317-322

Informa Healthcare

Access to resources Recommend Favorite

Effects of Gemcitabine on renal function in patients with non-small cell lung cancer

By Gietema J.A. Groen H.J.M. Meijer S. Smit E.F.

European Journal of Cancer, Vol. 34, Iss. 1, 1998-01 ,pp. : 199-202

Elsevier

Access to resources Recommend Favorite

Gemictabine plus carboplatin in patients with advanced non-small cell lung cancer

By Park Se Jeong Seong Kyung Sun Lim Young-Hee An Chang Lee Sang Park Jeong Bang Soo Cho Eun Shin Dong Lee Jae

Medical Oncology, Vol. 22, Iss. 4, 2005-12 ,pp. : 359-366

Humana Press, Inc

Access to resources Recommend Favorite

Sex differences in survival in non-small cell lung cancer patients 1974-1998

By Moore Rhonda Doherty Dorota Chamberlain Robert Khuri Fadlo

Acta Oncologica, Vol. 43, Iss. 1, 2004-03 ,pp. : 57-64

Informa Healthcare

Access to resources Recommend Favorite